Tonix Pharmaceuticals (TNXP) Misses Q4 EPS by 2c

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q4 EPS of ($0.83), $0.02 worse than the analyst estimate of ($0.81).

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform
• General Mills (GIS) PT Lowered to $42 at Freedom Broker